Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Due to the COVID-19 pandemic, the global Metronidazole market size is estimated to be worth US$ 113 million in 2021 and is forecast to a readjusted size of US$ 109.1 million by 2028 with a CAGR of -0.5% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Metronidazole market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Metronidazole landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Global Metronidazole key players include CordenPharma Farchemia, Tongji Pharmaceutical, Aarti Drugs, Manav Drugs, etc.
China is the largest market, with a share about 90%, followed by India, and Europe, both have a share over 10 percent.
In terms of product, Glyoxal Process is the largest segment, with a share over 85%. And in terms of application, the largest application is Metronidazole Tablets, followed by Metronidazole Capsule, Metronidazole Injection, etc.
This report focuses on Metronidazole volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Metronidazole market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and India, etc.
Global Metronidazole Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Glyoxal Process
Ethidene Diamine Process
Others
Segment by Application
Metronidazole Tablets
Metronidazole Capsule
Metronidazole Injection
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Hongyuan Pharmaceutical
Yinhe Aarti Pharmaceutical
Saikang Pharmaceutical
Zhongan Pharmaceutical
Wuyao Pharmaceutical
Yichang Changjiang Pharmaceutical
Tongji Pharmaceutical
Hongda Pharmaceutical
Topsun Pharmaceutical
Unichem Laboratories
CordenPharma Farchemia
API Polpharma
Manav Drugs
Aarey Drugs & Pharmaceuticals
Aarti Drugs